Protagonist Therapeutics, Inc Interest Expense
Protagonist Therapeutics, Inc (PTGX) reported Interest Expense of $598.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-15.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2023-03-15
- Protagonist Therapeutics, Inc interest expense for the quarter ending 2020-12-31 was $127.00K.
- Protagonist Therapeutics, Inc interest expense for the quarter ending 2020-09-30 was $19.00K.
- Protagonist Therapeutics, Inc interest expense for the quarter ending 2020-06-30 was $209.00K.
- Protagonist Therapeutics, Inc interest expense for the quarter ending 2020-03-31 was $243.00K.
- Protagonist Therapeutics, Inc interest expense for fiscal 2020 was $598.00K, a 253.85% increase from fiscal 2019.
- Protagonist Therapeutics, Inc interest expense for fiscal 2019 was $169.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2020-12-31 | $127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $146.00K derived: sum of 2 quarters · filed 2023-03-15 | $355.00K derived: sum of 3 quarters · filed 2023-03-15 | $598.00K 10-K · filed 2023-03-15 |
| 2020-09-30 | $19.00K 10-Q · filed 2021-11-03 | $228.00K derived: sum of 2 quarters · filed 2021-11-03 | $471.00K 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $209.00K 10-Q · filed 2021-08-04 | $452.00K 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $243.00K 10-Q · filed 2021-05-04 | |||
| 2019-12-31 | $169.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |